Skip to Main Content

Paper Details

An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331).
Adv Radiat Oncol
2
2022
Author NameAffiliation
Jeff M MichalskiWashington University School of Medicine
  • 1 - 1

Datasets

Release 1.2